Pilot Study of Redirected Autologous T Cells Engineered to Contain Humanized Anti-CD19 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma Previously Treated With Cell Therapy
Clinical trial NCT02374333 · COMPLETED
Trial details
- NCT number
- NCT02374333
- Sponsor
- University of Pennsylvania
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-25
- Primary completion
- 2021-09-02
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.